SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Essential Medicines Are More Available than Other Medicines around the Globe
4 references·9 citing·27 second hop
Essential Medicines Are More Available than Other Medicines around the Globe (2014)Essential Medicines Are More Available th…Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved? (2012)Switching from Originator Bra…Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries (2011)Differences in the availabili…Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data (2010)Availability, price and affor…Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…Selection and Use of Essential Medicines (2023)Selection and Use of Essentia…Availability and Prices of WHO Essential Diagnostics in Laboratories in West Africa: A Landscape Survey of Diagnostic Testing in Northern Ghana (2020)Availability and Prices of WH…Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)Access to Cardiovascular Dise…The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study (2019)The availability, prices and …Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology (2019)Evaluating medicine prices, a…Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases (2018)Modernizing the World Health …The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China (2017)The impacts of implementation…Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views (2017)Medicine shortages in Fiji: A…Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access (2016)Availability and affordabilit…Catastrophic payments for health care in Asia (2007)The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (2018)The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review (2018)Household catastrophic health expenditure: a multicountry analysis (2003)Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries (2016)Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases (2017)Projections of Global Mortality and Burden of Disease from 2002 to 2030 (2006)Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries (2020)Federal Democratic Republic of Ethiopia (2020)Driving a decade of change: HIV/AIDS, patents and access to medicines for all (2011)Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2015)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia (2007)Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases (2016)Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and national age–sex specifi c all-cause andcause-specifi c mortality for 240 causes of death, 1990–2013:a systematic analysis for the Global Burden of DiseaseStudy 2013 (2015)Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications (2020)Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh (2022)Rural‒urban disparities in household catastrophic health expenditure in Bangladesh: a multivariate decomposition analysis (2024)Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Essential medicines and human rights: what can they learn from each other? (2006)The reform of the essential medicines system in China: a comprehensive approach to universal coverage (2013)THE WORLD MEDICINES SITUATION 2011 (2011)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)
this work references cited by second hop

References

  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2011Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries187 cited
  • 2010Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data180 cited
  • 2012Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?178 cited

Cited by

  • 2020Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability120 cited
  • 2023Selection and Use of Essential Medicines104 cited
  • 2019Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology86 cited
  • 2019The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study79 cited
  • 2018Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases59 cited
  • 2016Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access57 cited
  • 2017Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views57 cited
  • 2020Availability and Prices of WHO Essential Diagnostics in Laboratories in West Africa: A Landscape Survey of Diagnostic Testing in Northern Ghana

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

20 cited
  • 2017The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China20 cited